Area Under the Expiratory Flow-Volume Curve (AEX): Assessing Bronchodilator Responsiveness.


Journal

Lung
ISSN: 1432-1750
Titre abrégé: Lung
Pays: United States
ID NLM: 7701875

Informations de publication

Date de publication:
06 2020
Historique:
received: 07 01 2020
accepted: 11 03 2020
pubmed: 27 3 2020
medline: 5 8 2021
entrez: 27 3 2020
Statut: ppublish

Résumé

Area under expiratory flow-volume curve (AEX) is a useful spirometric tool in stratifying respiratory impairment. The AEX approximations based on isovolumic flows can be used with reasonable accuracy when AEX is unavailable. We assessed here pre- to post-bronchodilator (BD) variability of AEX The BD response was assessed in 4330 subjects by changes in FEV Using standard BD criteria, 24% of subjects had a positive response. Using the new BD response categories, only 23% of subjects had a negative response; 45% minimal, 18% mild, 9% moderate, and 5% had a marked BD response. Mean percent change of the square root AEX Mean pre- to post-BD variability of AEX

Sections du résumé

BACKGROUND
Area under expiratory flow-volume curve (AEX) is a useful spirometric tool in stratifying respiratory impairment. The AEX approximations based on isovolumic flows can be used with reasonable accuracy when AEX is unavailable. We assessed here pre- to post-bronchodilator (BD) variability of AEX
METHODS
The BD response was assessed in 4330 subjects by changes in FEV
RESULTS
Using standard BD criteria, 24% of subjects had a positive response. Using the new BD response categories, only 23% of subjects had a negative response; 45% minimal, 18% mild, 9% moderate, and 5% had a marked BD response. Mean percent change of the square root AEX
CONCLUSIONS
Mean pre- to post-BD variability of AEX

Identifiants

pubmed: 32211978
doi: 10.1007/s00408-020-00345-2
pii: 10.1007/s00408-020-00345-2
pmc: PMC7242267
doi:

Substances chimiques

Bronchodilator Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

471-480

Références

Int J Chron Obstruct Pulmon Dis. 2019 Feb 14;14:409-418
pubmed: 30863041
Bull Eur Physiopathol Respir. 1982 May-Jun;18(3):419-25
pubmed: 7074238
Eur Respir J. 2005 Nov;26(5):948-68
pubmed: 16264058
Chest. 2014 Sep;146(3):541-542
pubmed: 25180719
Chest. 2014 Sep;146(3):538-541
pubmed: 25180718
Pneumologie. 2015 Apr;69(4):199-206
pubmed: 25853269
Eur Respir J. 2005 Jul;26(1):153-61
pubmed: 15994402
Eur J Respir Dis Suppl. 1986;143:18-21
pubmed: 3527734
Chest. 2014 Sep;146(3):536-537
pubmed: 25180717
Chest. 2017 May;151(5):1088-1098
pubmed: 28040521
Eur Respir J. 2019 Sep 5;54(3):
pubmed: 31221806
Respir Care. 2016 Nov;61(11):1505-1512
pubmed: 27555617
J Appl Physiol (1985). 2009 Aug;107(2):408-16
pubmed: 19541741
Respirology. 2019 Jul;24(7):638-645
pubmed: 30838750
Am Rev Respir Dis. 1991 Nov;144(5):1202-18
pubmed: 1952453
Chest. 1999 Aug;116(2):276-7
pubmed: 10453850
Pediatr Pulmonol. 2003 Mar;35(3):200-7
pubmed: 12567388
J Appl Physiol (1985). 1987 Mar;62(3):1324-30
pubmed: 3553143
Chest. 2014 Sep;146(3):542-544
pubmed: 25180720
Thorax. 1968 Nov;23(6):590-7
pubmed: 4388005
Ann Am Thorac Soc. 2019 Dec;16(12):1504-1517
pubmed: 31404502
J Investig Med. 2017 Feb;65(2):301-310
pubmed: 27543607
Respir Med. 2008 Dec;102(12):1777-83
pubmed: 18701269
BMJ Open Respir Res. 2019 Nov 24;6(1):e000511
pubmed: 31803477
Chest. 1993 Oct;104(4):1119-26
pubmed: 8404178
Chest. 2015 Dec;148(6):1489-1496
pubmed: 26226215
Am Rev Respir Dis. 1981 Feb;123(2):185-9
pubmed: 7235357
J Investig Med. 2020 Feb;68(2):403-411
pubmed: 31511309
Respiration. 2008;75(1):40-7
pubmed: 17299253
Ann Am Thorac Soc. 2020 May;17(5):582-588
pubmed: 31899663
Ann Am Thorac Soc. 2019 Jul;16(7):826-835
pubmed: 30908927
J Appl Physiol (1985). 2006 Aug;101(2):430-8
pubmed: 16497846
Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
pubmed: 7663792
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Am Rev Respir Dis. 1985 Oct;132(4):858-64
pubmed: 4051321
Thorax. 2003 Aug;58(8):659-64
pubmed: 12885978
J Appl Physiol (1985). 2007 Jan;102(1):269-75
pubmed: 16959912

Auteurs

Octavian C Ioachimescu (OC)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, School of Medicine, Emory University, Atlanta VA Sleep Medicine Center, 250 N Arcadia Ave, Decatur, GA, 30030, USA. oioac@yahoo.com.

James K Stoller (JK)

Education Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH